Efficacy of amino acids for treatment of neurological disease


Infantile cerebral palsy (ICP)

The infantile cerebral palsy (ICP) is known as one of the most common disease of the nervous system in infancy. The use of amino acids compounds for treatment of infantile cerebral palsy (ICP) has well pronounced effects for the following pathology associated with infantile cerebral palsy (ICP):
Details

Stroke and head trauma

In this wide group of patients with various neurological symptoms, well-pronounced results can be achieved, especially with early administration after the occurrence. Positive changes are observed in 80% of cases according to the time interval after the occurrence.
Details

Mental and speech retardation

Administration of amino acid compounds is very effective for treatment of children suffering from delayed mental development, speech disorder and oligophrenia of a various etiology and severity, irrespective of the severity.
Details

Amyotrophic lateral sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, which is characterised by a loss of cerebral and spinal motor neurons (with saving of extraocular and sphincter muscles). It usually manifests itself in the 6th or 7th decade of life, but can also occur much earlier. The disease has several clinical forms, a traditional form of amyotrophic lateral sclerosis (ALS)
Details

Down syndrome and other hereditary diseases

Our long-term experience in administration of amino acids in infants with Down syndrome shows well-pronounced results in all cases. Children with Down syndrome improve in speech, cognitive function, physical developments and social behavior.In many cases the typical face features of this group of infants who have received amino acids become less expressed.
Details

Multiple sclerosis

Multiple sclerosis is a chronic, long-term disease of the CNS (brain and spinal cord) of unknown etiology which is classified among auto-immune diseases. Sclerotic foci – plaques – cause an inflammation around the nerve fibers, which lose their myelin covers.
Details

Epilepsy

Treatment with our amino-acid preparations effectively supplements classic medicamentous anti-epileptic therapy. In many cases it brings a reduction of the frequency of epileptic seizures by up to 50-75%, and in some cases epileptic seizures are eliminated completely. It also produces a change in the character of epileptic seizures – from generalised seizures they become partial and/or are only short-term.
Details

Parkinson’s disease

Pathogenetic mechanisms of the development of Parkinson’s disease are explained by a lack of dopamine, a neurotransmitter which ensures the transfer of signals between neurons. A loss of dopamine-producing neurons occurs in the area of the brain known as “substantia nigra”. I
Details

Autism

Amino acid compounds could be highly recommended for treatment of different forms of autism. The following effects can be observed during the treatment of autistic children:
Details